Thermo Fisher (TMO) expects Q2 adj. EPS USD 0.25-0.30 higher than Q1 (Q1 EPS 5.44)

Thermo Fisher's indication of a potential increase in Q2 adjusted EPS signals positive momentum compared to Q1. This could suggest strong demand or effective cost management, which might influence investor sentiment and provide a boost to TMO's share price. Additionally, if these trends are indicative of broader sector health, there could be implications for related equities and the life sciences market overall.